Is this email not displaying correctly? View it in your browser.
Newswise - News for Journalists
Newswise Special Wire
Tuesday, June 25, 2019

Public edition |

Newswise Cancer Research Wire for 25-Jun-2019

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.

Cancer Research

Finding Missing Network Links Could Help Develop New Drugs, Stop Disease, Ease Traffic

A new mathematical model of the structure of networks could help find new cancer drugs, speed up traffic flow and combat sexually transmitted disease. Although the three challenges seem diverse, they all could benefit from a theory that helps uncover...

– American Institute of Physics (AIP)


Embargo expired on 25-Jun-2019 at 11:00 ET

By Cannibalizing Nearby Stromal Stem Cells, Some Breast Cancer Cells Gain Invasion Advantage

Researchers at the University of Michigan Rogel Cancer Center and U-M College of Engineering have found that breast cancer cells that swallow up nearby stem cells take on some of their properties, enhancing their ability to invade other tissues throu...

– Michigan Medicine - University of Michigan

Cell Reports

Embargo expired on 25-Jun-2019 at 11:00 ET

Scientists discover new method for developing tracers used for medical imaging

Scientists from University of North Carolina Lineberger Comprehensive Cancer Center have discovered a method for creating radioactive tracers used in PET imaging.

– University of North Carolina Health Care System

Science, June-2019

Embargo expired on 20-Jun-2019 at 14:00 ET

Small shops, heavy advertisers less likely to ID for tobacco

“Our findings suggest that certain types of stores — tobacco shops, convenience stores and those with a lot of tobacco advertising — are more likely to sell tobacco to a young person without checking his or her ID."

– Ohio State University

American Journal of Health Promotion

Engineered Cell Evolution May Provide Pathway to Halting Cancer Drug Resistance

Scientists in recent years have hypothesized that cell-cell differences aides the emergence of drug resistance. A new study published online in Nature Communications has tested this theory and yielded findings that may provide a path to reduce chemot...

– Stony Brook University

Nature Communications

To kill tumors, activate this elite group of T cells

Tissue-resident memory T cells (TRMs) are known to help the body fight infection, but they are also key tumor fighters. A new study reveals that these cells are unique in their ability to seek out and kill tumor cells without suffering from the commo...

– La Jolla Institute for Immunology

Journal of Experimental Medicine; S10 RR027366; S10OD016262; S10OD025052-01

Sinai Researchers Find Link Between Exposure to World Trade Center Dust and Prostate Cancer

World Trade Center (WTC) responders with prostate cancer showed signs that exposure to dust from the World Trade Center site had activated chronic inflammation in their prostates, which may have contributed to their cancer, according to a study by Mo...

– Mount Sinai Health System

Molecular Cancer Research, Jun-2019

More Than 5 Million Cancer Survivors Experience Chronic Pain, Twice the Rate of the General Population

More than 5 million cancer survivors in the United States experience chronic pain, almost twice the rate in the general population, according to a study published by Mount Sinai researchers

– Mount Sinai Health System

JAMA Oncology, June-2019

Estudio: se necesitan tratamientos más agresivos para mejorar la tasa de supervivencia a 5 años del glioblastoma

Pese a las mejores tasas de supervivencia promedio y a corto plazo de los pacientes con el tumor cerebral más frecuente entre los adultos, conocido como glioblastoma, todavía es bajo el porcentaje que logra sobrevivir 5 años según un estudio de M...

– Mayo Clinic

Mayo Clinic Proceedings

Many Elderly Patients with Metastatic Renal Cell Carcinoma Benefit from Targeted Therapies

Many elderly patients with metastatic renal cell carcinoma (RCC)—who are often underrepresented in clinical trials to treat the kidney cancer—are seeing overall survival benefits from treatment with targeted therapies, according to a new study fr...

– Perelman School of Medicine at the University of Pennsylvania

JAMA Network Open

TuBA: A New Computational Tool to Tune Molecular Classification of Tumors

Investigators at Rutgers Cancer Institute of New Jersey have developed a computational method that uncovers clinically relevant gene expression patterns in large cohorts of breast cancer patients. This method, which is applicable to the analysis of a...

– Rutgers Cancer Institute of New Jersey

GigaScience, Jun-2019

Researchers Find Cause of Rare, Fatal Disease That Turns Babies’ Lips and Skin Blue

Scientists used a gene editing method called CRISPR/Cas9 to generate mice that mimic a respiratory disorder in newborn infants that turns their lips and skin blue. The new laboratory model allowed researchers to find the ailment’s cause and a poten...

– Cincinnati Children's Hospital Medical Center

American Journal of Respiratory and Critical Care Medicine, June 14, 2019

Huntsman Cancer Institute Research Discovery Leads to New Clinical Trial for Myelofibrosis Patients

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

– Huntsman Cancer Institute at the University of Utah

Clinical Cancer Research

Microfluidics Device Captures Circulating Cancer Cell Clusters

About 90% of cancer deaths are due to metastases, when tumors spread to other vital organs, and a research group recently realized that it’s not individual cells but rather distinct clusters of cancer cells that circulate and metastasize to other o...

– American Institute of Physics (AIP)

AIP Advances


根据Mayo Clinic对最常见遗传性综合征和病症的综述,在所有结直肠癌和乳腺癌病例中,5%–10%与遗传因素有关。

– Mayo Clinic

Cancer Experts and Features

American Society for Radiation Oncology (ASTRO) to host Annual Meeting in Chicago, September 15-18

The American Society for Radiation Oncology (ASTRO) will host its 61st Annual Meeting at McCormick Place in Chicago, September 15-18, 2019. The meeting will feature updates on clinical trials, cancer research and new approaches that involve radiatio...

– American Society for Radiation Oncology (ASTRO)

Chemotherapy Heart

Cancer patients obviously need chemotherapy treatment, but many don't realize some forms can cause heart failure. The premise here is that people need to be alerted while undergoing chemotherapy treatment because if caught early the heart disease can...

– Houston Methodist

Immunotherapy-Chemo Combo Based on Work of Roswell Park’s Dr. Ben Seon Gets FDA Approval

A cancer therapy based on the work of Ben Seon, PhD, at Roswell Park Comprehensive Cancer Center has been approved by the U.S. Food and Drug Administration (FDA) for patients with an aggressive form of non-Hodgkin lymphoma.

– Roswell Park Comprehensive Cancer Center

Cover up to reduce the risk of short- and long-term skin damage from the sun’s UV rays

If you let the sun burn your skin you’ll pay a price right away, with painful redness, peeling and possible blistering. But sunburn can also generate long-term problems, such as premature aging of the skin and skin cancer.

Expert Available

– Wake Forest Baptist Medical Center

Leading Health and Technology Organizations Release Common Cancer Data Standards to Enable Sharing Across EHR Systems and Improve Patient Care

Three of the nation’s leading health and technology organizations have established a core set of data elements and recommended technical specifications (the Minimal Common Oncology Data Elements, or “mCODE”) that are essential for capturing and...


ASCO’s 2019 Annual Meeting

Cancer Announcements

Remembering Dr. Eugene P. Frenkel, who led Division of Hematology and Oncology for 30 years at UT Southwestern

Dr. Eugene P. Frenkel, an internationally recognized cancer researcher and admired clinician and educator who pioneered UT Southwestern Medical Center’s Division of Hematology and Oncology, died June 21, 2019. He was 89.

– UT Southwestern Medical Center

MSK-ACCESS Receives New York State Approval for New Molecular Assay

Memorial Sloan Kettering Cancer Center (MSK) announced that the New York State Department of Health has issued an approval for a new molecular assay called Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS).

– Memorial Sloan Kettering Cancer Center

Cancer Research Institute Names New Stars of Cancer Immunotherapy Research

Five U.S. scientists have been awarded $1.25 million each from the Cancer Research Institute to carry out high-risk, high-reward cancer immunology research with potential to transform cancer treatment

– Cancer Research Institute

Cancer Research Institute Hosts Inaugural “Immuno-Oncology: A Future Look” Media and Investor Event in New York City

The Cancer Research Institute (CRI) will host its inaugural “Immuno-Oncology: A Future Look” event for healthcare investment analysts and media today in New York City at the New York Academy of Sciences from 10:00 am – 12:00 pm ET.

– Cancer Research Institute

SOFIE And University Clinic Heidelberg Sign License Agreement For Theranostics That Target Cancer Associated Fibroblasts

SOFIE Inc. (SOFIE), a Theranostics company, is pleased to announce an exclusive global license with University Clinic Heidelberg (UKHD) for a class of molecular targeted diagnostics


NCCN and AstraZeneca Seek Opportunities to Improve Outcomes in Advanced Ovarian Cancer

NCCN Oncology Research Program (ORP) issues request for proposals to improve quality of care for people with stage III, stage IV, and recurrent epithelial ovarian cancer.

– National Comprehensive Cancer Network® (NCCN®)

RWJBarnabas Health and Rutgers Cancer Institute of New Jersey Announce New $750 Million State-of-the-Art, Free-Standing Cancer Pavilion in New Brunswick

RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, in partnership with New Brunswick Development Corporation announced the development of a new, state-of-the-art, free-standing cancer pavilion in New Brunswick. The initial estimated proje...

– Rutgers Cancer Institute of New Jersey

Mayo Clinic to host Sixth Annual Metastatic Breast Cancer Conference

Mayo Clinic will host the Sixth Annual Metastatic Breast Cancer Conference at the Omni Scottsdale Resort and Spa at Montelucia in Scottsdale, Arizona, Sept. 19–20. This program is a joint effort among Mayo Clinic, Baylor College of Medicine, and Th...

– Mayo Clinic

6th Annual Metastatic Breast Cancer Conference, September 19-20, 2019





 Edit My Preferences
 Contact Us
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 American Institute of Physics (AIP)

 UT Southwestern Medical Center

 Michigan Medicine - University of Michigan

 Stony Brook University

Subscribe / Unsubscribe
Edit my preferences

© 2019 Newswise, Inc. All Rights Reserved.

215 E. 5th St. SW, Charlottesville VA 22903 | 434-296-9417

 Contact Us